Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease
慢波活动作为阿尔茨海默病神经变性进展的调节剂
基本信息
- 批准号:10205286
- 负责人:
- 金额:$ 19.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloid beta-ProteinAmyloid depositionAnimal Disease ModelsBrainCalciumCellsCerebral cortexChronicDataDepositionDisease ProgressionElectroencephalogramElectroencephalographyEnterobacteria phage P1 Cre recombinaseExhibitsGenerationsGlutamate DecarboxylaseHomeostasisImpaired cognitionImpairmentImplantInterneuronsLengthLightMeasuresMediatingMemoryMolecularMonitorMusNerve DegenerationNeuronal DysfunctionNeuronsNitric Oxide Synthase Type IPathogenesisPathologyPatternPopulationProductionPublicationsPublishingREM SleepSenile PlaquesSeveritiesSleepSleep ArchitectureSleep disturbancesSomatostatinThalamic structureWakefulnessabeta accumulationamyloid pathologybasecell typecognitive functiondesigner receptors exclusively activated by designer drugsextracellularimprovedmemory consolidationmouse modelmultiphoton microscopyneuroinflammationneuronal circuitryneurotransmissionnon rapid eye movementnovel therapeutic interventionoptical fiberoptogeneticssleep patternvoltage sensitive dye
项目摘要
Sleep-wake disruptions and cognitive impairments are prevalent and disabling features of Alzheimer's disease
(AD). AD patients exhibit profound sleep disturbances including disruption of non-rapid eye movement (NREM)
sleep. A major restorative feature of NREM sleep, which is also associated with proper cognitive functioning, is
slow-wave activity (SWA). Recent findings suggest a causal relationship between impaired generation of SWA
during sleep and AD pathogenesis including extracellular accumulation of the amyloid-β (Aβ) peptide and
neuronal dysfunction. While evidence indicates that cortical-thalamic loops regulate SWA, the exact cellular
and molecular mechanisms for impaired SWA in AD are unknown. Thus, a need exists to characterize the cells
and molecular mechanisms responsible for SWA generation to reduce the impairments in SWA and
pathogenesis of AD. We propose studies that will elucidate the sleep state related mechanisms by which SWA
protects against AD. Studies using AD animal models suggest that inhibitory neurotransmission is impaired
during periods of SWA. The overall objective of this proposal is to identify and stimulate specific SWA
modulating interneuronals to determine which cells restore SWA and mitigate AD-related pathology using an
established AD mouse model. Herein, we propose to employ optogenetics and chemogenetics to control
neuronal circuits aimed to restore SWA and slow AD progression. Thus, our findings will determine the cellular
and molecular relationships between sleep and AD, with the targeting of interneurons during specific periods of
sleep as a novel therapeutic approach.
睡眠-觉醒中断和认知障碍是阿尔茨海默病的普遍和致残特征
(AD)。AD患者表现出严重的睡眠障碍,包括非快速眼动(NREM)中断
睡吧NREM睡眠的一个主要恢复特征,也与适当的认知功能有关,
慢波活动(SWA)。最近的研究结果表明SWA的产生受损之间存在因果关系
在睡眠和AD发病机制,包括细胞外积累的淀粉样β(Aβ)肽,
神经元功能障碍虽然有证据表明,皮质-丘脑回路调节SWA,但确切的细胞调节机制是,
AD中SWA受损的分子机制尚不清楚。因此,需要表征细胞
以及负责SWA产生的分子机制,以减少SWA中的损伤,
AD的发病机制我们提出的研究将阐明睡眠状态相关的机制,其中SWA
保护AD。使用AD动物模型的研究表明,抑制性神经传递受损
在SWA期间。本提案的总体目标是确定和激励具体的SWA
调节神经元间,以确定哪些细胞恢复SWA并减轻AD相关的病理,
建立AD小鼠模型。在此,我们建议采用光遗传学和化学遗传学来控制,
神经元回路旨在恢复SWA和减缓AD进展。因此,我们的研究结果将确定细胞
以及睡眠和AD之间的分子关系,在特定的睡眠期间靶向中间神经元。
睡眠作为一种新的治疗方法。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer's disease model.
- DOI:10.1186/s13024-023-00682-9
- 发表时间:2023-12-01
- 期刊:
- 影响因子:15.1
- 作者:
- 通讯作者:
Optimization of real-time analysis of sleep-wake cycle in mice.
- DOI:10.1016/j.mex.2022.101811
- 发表时间:2022
- 期刊:
- 影响因子:1.9
- 作者:Thankachan, Stephen;Gerashchenko, Andrei;Kastanenka, Ksenia, V;Bacskai, Brian J.;Gerashchenko, Dmitry
- 通讯作者:Gerashchenko, Dmitry
Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer's disease.
- DOI:10.1038/s42003-022-04268-x
- 发表时间:2022-12-02
- 期刊:
- 影响因子:5.9
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian J Bacskai其他文献
Bringing amyloid into focus
将淀粉样蛋白置于焦点
- DOI:
10.1038/nbt0505-552 - 发表时间:
2005-05-01 - 期刊:
- 影响因子:41.700
- 作者:
Todd E Golde;Brian J Bacskai - 通讯作者:
Brian J Bacskai
Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide. Gordon Research Conferences, Neurobiology of brain disorders
载脂蛋白E,尤其是载脂蛋白E4,增加淀粉样β肽的寡聚化。
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Tadafumi Hashimoto;Alberto Serrano-Pozo;Yukiko Hori;Hwan-Ching Tai;Kenneth W Adams;Shuko Takeda;Daniel Joyner;Diana H Thyssen;Brian J Bacskai;Matthew P Frosch;Tara L Spires-Jones;Mary Beth Finn;David M Holtzman;and Bradley T Hyman - 通讯作者:
and Bradley T Hyman
Brian J Bacskai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian J Bacskai', 18)}}的其他基金
Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease
慢波活动作为阿尔茨海默病神经变性进展的调节剂
- 批准号:
10657937 - 财政年份:2019
- 资助金额:
$ 19.5万 - 项目类别:
Astrocytes as governing pathological drivers of neurovascular dysfunction in AD
星形胶质细胞是 AD 神经血管功能障碍的病理驱动因素
- 批准号:
10584240 - 财政年份:2017
- 资助金额:
$ 19.5万 - 项目类别:
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION
脑淀粉样蛋白血管病和脑淀粉样蛋白积累的机制
- 批准号:
9884824 - 财政年份:2016
- 资助金额:
$ 19.5万 - 项目类别:
Molecular pathways leading to neurodegeneration in vivo
导致体内神经变性的分子途径
- 批准号:
9472989 - 财政年份:2015
- 资助金额:
$ 19.5万 - 项目类别:
Molecular pathways leading to neurodegeneration in vivo
导致体内神经变性的分子途径
- 批准号:
8887495 - 财政年份:2015
- 资助金额:
$ 19.5万 - 项目类别:
A replacement multiphoton microscope for in vivo imaging in rodent models of neur
用于神经啮齿动物模型体内成像的替代多光子显微镜
- 批准号:
7595490 - 财政年份:2009
- 资助金额:
$ 19.5万 - 项目类别:
MULTIPHOTON MICROSCOPY FOR IN VIVO NEURAL IMAGING
用于体内神经成像的多光子显微镜
- 批准号:
7563694 - 财政年份:2007
- 资助金额:
$ 19.5万 - 项目类别:
Non-invasive optical imaging of neuropathology in vivo
体内神经病理学的无创光学成像
- 批准号:
7903375 - 财政年份:2006
- 资助金额:
$ 19.5万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别: